Aging Clinical Trials

A listing of Aging medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Arizona

Xenoscience
Phoenix Arizona 85004

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Territory Neurology & Research Institute
Tucson Arizona 85704

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

View More ▼

Glendale Arizona 85302

Effect of Dietary Supplementation on Dynamic Stability

California

Alliance Research Center
Laguna Hills California 92653

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Renew Behavioral Health, Inc.
Long Beach California 90807

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Excell Research, Inc.
Oceanside California 92056

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Asclepes Research Center
Panorama City California 91402

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Northern California Research
Sacramento California 95821

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

View More ▼

Monterey California 93940

A clinical study for patients with Aging

Florida

Bradenton Research Center
Bradenton Florida 34205

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Cardiology Research Associates
Daytona Beach Florida 32117

Type II Diabetic Patients at High Risk For Cardiovascular Events

IMIC, Inc.
Miami Florida 33157

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Panax Clincial Research LLC
Miami Lakes Florida 33014

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Neurostudies, Inc.
Port Charlotte Florida 33952

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Progressive Medical Research
Port Orange Florida 32127

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Stedman Clinical Trials
Tampa Florida 33613

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

View More ▼

UPDATED

Orlando Florida 32827

A clinical trial seeking patients for a research study for the treatment of Health Behavior, Quality of Life or Aging

The Villages Florida 32162

A clinical research study for the treatment of Early Onset Alzheimer Disease, Mild Cognitive Impairment, Depression or Aging

Illinois

Behavioral Health Care Associates
Schaumburg Illinois 60193

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Iowa

Iowa City Iowa 52242

A clinical trial seeking patients for a research study for the treatment of Age-related Cognitive Decline

Maine

Eastern Maine Medical Center
Bangor Maine 04401

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Massachusetts

ActivMed Research
Methuen Massachusetts 01844

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

View More ▼

Boston Massachusetts 02114

A clinical research study of Testosterone, Anastrazole and Goserelin acetate for the treatment of Healthy Volunteers

Boston Massachusetts 02130

A clinical trial seeking patients for a research study for the treatment of Age-related Cognitive Decline

Michigan

Bronson Neurobehavioral Health
Paw Paw Michigan 49079

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Missouri

Washington University
Saint Louis Missouri 63110

A Washington University metabolism research study seeks participants.

Washington University in St. Louis - Center for Clinical Studies
St. Louis Missouri 63130

A Washington University research study seeks participants for an online survey.

New Hampshire

ActiveMed
Portsmouth New Hampshire 03801

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

New Jersey

Memory Enhancement Center of America
Eatontown New Jersey 07724

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Premier Urology Associates, LLC
Lawrenceville New Jersey 08648

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

The NeuroCognitive Institute
Mt. Arlington New Jersey 07856

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

New Mexico

Albuquerque Neuroscience
Albuquerque New Mexico 87109

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

New York

Sadick Research Group
New York New York 10075

Single-Centre, Double-Blind, Randomized, Placebo-Controlled, Study of the Efficacy and Safety of the Hydropeptide® Nimni Repair Complex for Improving Facial Wrinkles and Skin Quality

Sadick Research Group
New York New York 10075

AN OPEN-LABEL, MULTI-CENTER TRIAL TO ASSESS THE SAFETY OF SINGLE AND REPEAT TREATMENTS OF DOXIBOTULINUMTOXIN-A FOR INJECTION FOR TREATMENT OF MODERATE TO SEVERE GLABELLAR LINES.

Medical Research Network
New York New York 10128

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Manhattan Behavioral Medicine
New York New York 10023

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Winifred Masterson Burke Medical Research Institute
White Plains New York 10605

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

North Carolina

ANI Neurology, PLLC Alzheimer's Memory Center
Charlotte North Carolina 28270

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

PMG Research of Winston-Salem
Winston-Salem North Carolina 27103

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Ohio

Columbus Research & Wellness Institute
Columbus Ohio 31904

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Oklahoma

Cutting Edge Research Group
Oklahoma City Oklahoma 73116

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Tulsa Clinical Research, Inc.
Tulsa Oklahoma 74114

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Pennsylvania

Pearl Clinical Research
Norristown Pennsylvania 19401

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Thomas Jefferson University
Philadelphia Pennsylvania 19107

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

South Carolina

Metrolina Neurological Associates, PA
Rock Hill South Carolina 29732

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Texas

ACRC Trials
Plano Texas 75024

Type 2 Diabetes with a high risk of Cardivascular Events

Grayline Clinical Drug Trials
Wichita Falls Texas 76309

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Utah

Wasatch Clinical Research
Salt Lake City Utah 84107

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Bulgaria

UMBAL "Dr. Georgi Stranski" EAD
Pleven International 5800

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease